Loading...

PR Information Data

154 개 2 페이지
번호 컨텐츠
139 Gwangju FC and Kuala Lumpur City FC sign mutual business agreement 2025-03-31   7 (주)아디포랩스
138 Gwangju FC and Kuala Lumpur City FC sign mutual business agreement 2025-03-31   8 (주)아디포랩스
137 Korea-Malaysia Relationship Blossoms with High-Frequency Hyperthermia Cancer Treatment Device ‘REMISSION 1℃’ 2025-03-31   9 (주)아디포랩스
136 AdipoLABs Announces REMISSION 1℃ Clinical Results at 6th IVRA 2025-03-31   10 (주)아디포랩스
135 “This is how I overcame cancer” IVRA International Cancer Treatment Seminar launches HOT 2024-07-30   648 (주)아디포랩스
134 Cancer patients should be given the opportunity to make their own choices regarding hyperthermia cancer treatment devices HOT 2024-07-30   621 (주)아디포랩스
133 AdipoLABs takes the lead in physical strength improvement and health care for Gwangju FC soccer players HOT 2024-07-30   729 (주)아디포랩스
132 AdipoLABs successfully cooperates in medical tourism with Sichuan Province, China HOT 2024-07-30   632 (주)아디포랩스
131 Cooperation between Korea and China to promote cancer patient treatment begins in earnest HOT 2024-07-30   605 (주)아디포랩스
130 AdipoLABs discusses the introduction of ‘REMISSION 1℃’ with the Mongolian Ministry of Health and Welfare HOT 2024-07-30   619 (주)아디포랩스
129 High-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ enters Mongolia in a matter of time HOT 2024-07-26   586 (주)아디포랩스
128 AdipoLABs, Grand Prize at ‘K-First in Class’ for 8 consecutive years HOT 2024-07-26   592 (주)아디포랩스
127 AdipoLABs enters the market with high-frequency hyperthermia cancer treatment device ‘REMISSION 1℃’ HOT 2024-07-11   640 (주)아디포랩스
126 “We will work harder for the development of the country and the company.” HOT 2024-07-11   637 (주)아디포랩스
125 AdipoLABs establishes a bridgehead to enter the Chinese market HOT 2024-07-11   650 (주)아디포랩스